🔎 Trials Near Me

መነሻ › የሳንባ ካንሰር › ኢሊኖይ › Cicero

በCicero፣ IL ለየሳንባ ካንሰር የሚደረጉ ክሊኒካዊ ጥናቶች

ለየሳንባ ካንሰር የሚደረጉ 17 ጥናቶች በCicero እና በአካባቢው ባሉ ቦታዎች (በወደ 30 ማይል ውስጥ) ተሳታፊዎችን እየፈለጉ ነው። ማን መሳተፍ እንደሚችል እና የጥናት ቡድኑን እንዴት መገናኘት እንደሚቻል ለማየት ጥናቱን ክፈቱ።

Official study text (English)

ለጥናት ተሳታፊዎችን እየፈለጉ ነው? በዚህ ገጽ ላይ በ$99 ለ30 ቀናት ያስቀምጡት →

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Edward Hines Jr VA Hospital, Hines · 4 ማይል ርቀት
  • Advocate Christ Medical Center, Oak Lawn · 9 ማይል ርቀት
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ2 ኦክቶ 2026 · NCT04267848

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

ተሳታዮችን በመፈለግ ላይየመመልከት ጥናትጤናማ ተሳታዮች ይቀበላሉ
  • OSF Little Company of Mary Medical Center, Evergreen Park · 9 ማይል ርቀት
  • Advocate Christ Medical Center, Oak Lawn · 9 ማይል ርቀት
እድሜ ከ40 እስከ 75 · ሁሉም ጾታዎች · የተሻሻለው በ2 ኦክቶ 2026 · NCT05334069

Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Advocate Christ Medical Center, Oak Lawn · 9 ማይል ርቀት
እድሜ 70 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ1 ኦክቶ 2026 · NCT06096844

Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Northwestern Medicine Oak Brook, Oak Brook · 9 ማይል ርቀት
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ1 ኦክቶ 2026 · NCT04181060

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Northwestern Medicine Oak Brook, Oak Brook · 9 ማይል ርቀት
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ1 ኦክቶ 2026 · NCT06498635

Symbiotic-Lung-14: A Study to Learn About the Study Medicine Called PF08634404 in Combination With Chemotherapy in Adult Participants With Transformed Small Cell Lung Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • Hope and Healing Clinical Research, Hinsdale · 10 ማይል ርቀት
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ28 ሴፕቴ 2026 · NCT07476287

Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Hope and Healing Cancer Services, Hinsdale · 10 ማይል ርቀት
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ25 ሴፕቴ 2026 · NCT07222566

Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLC

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • Hope and Healing Clinical Research, Hinsdale · 10 ማይል ርቀት
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ25 ሴፕቴ 2026 · NCT07489066

This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Advocate Christ Medical Center, Oak Lawn · 9 ማይል ርቀት
  • Hope and Healing Cancer Services, Hinsdale · 10 ማይል ርቀት
  • Endeavor Health, Elmhurst · 10 ማይል ርቀት
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ25 ሴፕቴ 2026 · NCT06758401

A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Affiliated Oncologists, LLC, Chicago Ridge · 10 ማይል ርቀት
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ8 ሴፕቴ 2026 · NCT06793215

Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer

ተሳታዮችን በመፈለግ ላይደረጃ 3
  • Advocate Christ Medical Center, Oak Lawn · 9 ማይል ርቀት
  • Advocate High Tech Medical Park, Palos Heights · 12 ማይል ርቀት
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ17 ኦገስ 2026 · NCT05624996

Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • Rush MD Anderson Cancer Center at Rush Oak Park, Oak Park · 3 ማይል ርቀት
  • Edward Hines Jr VA Hospital, Hines · 4 ማይል ርቀት
  • Loyola University Medical Center, Maywood · 5 ማይል ርቀት
  • እና 2 ተጨማሪ
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ3 ጁን 2026 · NCT05642572

MYLUNG Consortium Part 3: Observational Study

ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
  • Affiliated Oncologists, LLC, Chicago Ridge · 10 ማይል ርቀት
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ18 ሜይ 2026 · NCT05885698

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)

ተሳታዮችን በመፈለግ ላይደረጃ 2
  • Edward Hines Jr VA Hospital, Hines · 4 ማይል ርቀት
  • Loyola University Medical Center, Maywood · 5 ማይል ርቀት
  • Northwestern Medicine Oak Brook, Oak Brook · 9 ማይል ርቀት
18 Minutes · ሁሉም ጾታዎች · የተሻሻለው በ5 ሜይ 2026 · NCT06031688

Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)

ተሳታዮችን በመፈለግ ላይደረጃ 2/3
  • Loyola University Medical Center, Maywood · 5 ማይል ርቀት
  • Northwestern Medicine Oak Brook, Oak Brook · 9 ማይል ርቀት
  • Advocate Christ Medical Center, Oak Lawn · 9 ማይል ርቀት
  • እና 2 ተጨማሪ
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ5 ሜይ 2026 · NCT06616584

Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy

ተሳታዮችን በመፈለግ ላይ
  • Edward Hines Jr. VA Hospital, Hines, IL, Hines · 4 ማይል ርቀት
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ19 ፌብሩ 2026 · NCT02984761

LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia

ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
  • Advocate Christ Medical Center, Oak Lawn · 9 ማይል ርቀት
  • Advocate Outpatient Center - Oak Lawn, Oak Lawn · 9 ማይል ርቀት
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ9 ጃንዩ 2026 · NCT06073431

በሌሎች ከተሞች ለየሳንባ ካንሰር የሚደረጉ ጥናቶች

በCicero ውስጥ ያሉ ሌሎች ጥናቶች

ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ5 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።